期刊文献+

星形细胞瘤中PTEN、Mdm2和p53表达的相关性研究 被引量:9

Relationship of PTEN,Mdm2 and p53 expression in astrocytoma
原文传递
导出
摘要 目的 探讨不同组织病理分级的星形细胞瘤中PTEN、Mdm2和p5 3的表达水平 ,并分析PTEN影响Mdm2和p5 3表达的信号转导机制。方法 采用免疫组织化学方法检测 6 8例星形细胞瘤标本中 ,PTEN、Mdm2和p5 3的表达水平。结果 星形细胞瘤中 ,PTEN、Mdm2和p5 3的表达水平分别为 5 4 .4 % (37/ 6 8)、4 1.2 % (2 8/ 6 8)和 4 5 .6 % (31/ 6 8)。PTEN阳性标本中 ,Mdm2的表达率 (2 4 .3% ,9/ 37)与PTEN阴性标本中该蛋白的表达率 (6 1.3% ,19/ 31)相比 ,差异有显著性 ,统计学分析显示 ,PTEN表达与Mdm2表达呈负相关 (P <0 .0 1)。Mdm2表达和p5 3表达一致 ,符合率为 6 6 .2 % (45 / 6 8) ,两者的表达密切相关 (P <0 .0 5 )。结论 PTEN、Mdm2和p5 3表达与星形细胞瘤的组织病理分级相关 ;抑癌基因PTEN可以下调癌基因Mdm2的表达水平 ;Mdm2和p5 3的表达存在一致性。 Objective To study the incidence of PTEN, Mdm2 and p53 expression in different histopathological grades of astrocytoma and the signal transduction mechanism through which PTEN affects Mdm2 and p53 expression. Methods Surgical specimens from 68 brain astrocytoma patients were analyzed to detect PTEN, Mdm2 and p53 expression by immunohistochemical method. Results The incidence of PTEN, Mdm2 and p53 expression was 54.4% (37/68), 41.2% (28/68) and 45.6% (31/68). The positive incidence of Mdm2 was 24.3% (9/37) in 37 cases with PTEN expression and 61.3%(19/31)in 31 cases without, which had a negative correlation between Mdm2 expression and PTEN expression(P<0.01). Eighteen cases showed Mdm2(+)/p53(+) and 27 cases showed Mdm2(-)/p53(-). A significant correlation was found between Mdm2 and p53 expression(P<0.05). Conclusion The histopathological grade of astrocytoma is correlated with the loss of PTEN expression, Mdm2 amplification and p53 mutation. Mdm2 amplification, being in accordance with p53 mutation, can be inhibited by PTEN expression.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2003年第5期478-481,共4页 Chinese Journal of Oncology
基金 广州科技局重点攻关项目 (2 0 0 1 Z 0 3 0 1 2 ) 广东省自然科学基金研究团队项目 (0 15 0 12 )
关键词 星形细胞瘤 PTEN MDM2 P53 表达 相关性研究 信号转导 免疫组织化学 Astrocytoma PTEN Mdm2 p53 Signal transduction Immunohistochemistry
  • 相关文献

参考文献10

  • 1Mayo LD, Dixon JE, Durden DL, et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Churn, 2002, 277:5484-5489.
  • 2Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995. 80:225-236.
  • 3Roux P. PTEN: a tumor suppressor with original properties. Bull Cancer, 1999,86: 522-525.
  • 4Rasheed BK, Stenzel qT, McLendon RE, et al. PTEN gene mutationssare seen in high-grade but not in low-grade gliomas. Cancer Res, 1997,57: 4187-4190.
  • 5Lin H, Bondy ML, Langford LA, et al. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. Clin Cancer Res, 1998, 4: 2447-2454.
  • 6Stambolic V, Smarki A, de la Poma JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell,1998, 95:29-39.
  • 7Haas-Kogan D, Shalev N, Wong M, et al. Protein kinase B (PKB/Akt)activity is elevated in glioblastoma cells due to mutation of the tumor suppressor FFEN/MMAC. Curr Biol, 1998,8: 1195-1198.
  • 8Fakharzadeh SS, Rosenblum-Vos L, Murphy M, et al. Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene. Genomics, 1993, 15: 283-290.
  • 9Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Nail Acad Sci USA, 2001, 98, 11298-11603.
  • 10Oliner JD, Pietenpol JA, Thiagalingam S, et al. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature, 1993,362: 857-860.

同被引文献43

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部